![](/img/cover-not-exists.png)
Abstracts: 12th Annual Conference of the International Society for Quality of Life Research (ISOQOL) || P-36/1678/qol Outcomes during Long-Term Treatment with Darifenacin for Overactive Bladder (OAB): A 2-Year, Open-Label Extension Study
Jay Young, Karine Lheritier and Peter DwyerVolume:
14
Language:
english
Journal:
Quality of Life Research
DOI:
10.2307/4039560
Date:
November, 2005
File:
PDF, 341 KB
english, 2005